nocodazole has been researched along with mechlorethamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Draetta, G; Ferris, DK; Hoffmann, I; Jackman, J; Kohn, KW; O'Connor, PM | 1 |
Bae, I; Bhatia, K; el-Deiry, WS; Fan, S; Fornace, AJ; Freeman, J; Jondle, D; Kohn, KW; Magrath, I; O'Connor, PM | 1 |
Grunicke, H; Hofmann, J; Jackman, J; Kohn, KW; O'Connor, PM; Schubert, C; Ueberall, F | 1 |
3 other study(ies) available for nocodazole and mechlorethamine
Article | Year |
---|---|
Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard.
Topics: Aphidicolin; Burkitt Lymphoma; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle Proteins; Cell Line; G2 Phase; HeLa Cells; Humans; Interphase; Kinetics; Mechlorethamine; Nocodazole; Proteins; Time Factors; Tumor Cells, Cultured | 1994 |
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Topics: Apoptosis; Burkitt Lymphoma; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Flow Cytometry; G1 Phase; Gamma Rays; Genes, p53; Humans; Lymphocytes; Mechlorethamine; Mutation; Nocodazole; Radiation Tolerance; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1994 |
The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents.
Topics: Alkaloids; Antineoplastic Agents; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Cycle; Cell Line; DNA Damage; Dose-Response Relationship, Radiation; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; G2 Phase; Humans; Kinetics; Mechlorethamine; Nocodazole; Phospholipid Ethers; Protein Kinase C; Radiation, Ionizing; Staurosporine; Tumor Cells, Cultured | 1994 |